Skip to content
Clinical Trials – home

CTC Clinical Trial Consultants AB

Verified siteinfoFast reply

Sweden Dag Hammarskjolds Vag 14, Uppsala Domkyrkofors., 752 37 Uppsala, Sweden

  • 5 trials recruiting
  • Obesity · Idiopathic pulmonary fibrosis · Coeliac disease
  • Adults and children

About Specializations

CTC Clinical Trial Consultants AB in Uppsala, Sweden specialises in clinical trials of conditions such as Obesity, Idiopathic pulmonary fibrosis, Coeliac disease, Migraine, and other specialisations. This site conducts important research.

Main research areas of the site

Nutritional and Metabolic Diseases

The research at CTC Clinical Trial Consultants AB emphasizes conditions such as obesity and overweight, seeking to test new therapies that support weight reduction and improve metabolic health.

  • Appetite regulation strategies
  • Energy balance and metabolic rate studies
  • Pharmacokinetic profiling of weight‑loss agents
  • Safety and tolerability in metabolic cohorts

Across five early‑phase trials, a team of twenty investigators in Uppsala is advancing therapeutic options for metabolic disease.

Respiratory Tract Diseases

The program focuses on chronic lung illnesses like chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis, evaluating innovative treatments to preserve lung function and enhance patient quality of life.

  • Inhaled drug delivery platforms
  • Anti‑fibrotic therapeutic candidates
  • Biomarker development for disease progression
  • Safety assessments in pulmonary populations

With five active studies and twenty researchers, the Uppsala‑based site is driving forward new therapeutic strategies for respiratory health.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Dag Hammarskjolds Vag 14, Uppsala Domkyrkofors.752 37 UppsalaSweden
Recruiting now
5 trials
Conditions studied
21
Partner status
Verified site

More sites in UppsalaSweden

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

26 clinical trials

Bronchiectasis

Recruiting

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Investigational
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:BI 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Seltorexant
  • Sponsor:Janssen Cilag International

Coeliac disease

Recruiting

Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH

Hidradenitis

Recruiting

A safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:SAR445399
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Rectal cancer

Recruiting

Study on the Safety and Dosage of Ferumoxtran-10 for Examining Lymph Nodes in Rectal Cancer Patients Using NanoEcho Imaging Device

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:FERUMOXTRAN-10
  • Sponsor:NanoEcho AB (publ)

Parkinson's disease

Not yet recruiting

A Randomized Trial of lu af28996 dh1 to Reduce Motor Fluctuations in Adults with Parkinson’s Disease

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Sponsor:H. Lundbeck A/S

Coeliac disease

Not recruiting

Study on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Obesity

Not recruiting

Orlistat (EMP22) and Drug Combination (acarbose + orlistat) in Healthy Volunteers with Obesity

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Acarbose
  • Sponsor:Empros Pharma AB

EP395 and drug combination (verapamil, midazolam, digoxin) pharmacokinetic study in healthy volunteers with COPD

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Digoxin
  • Sponsor:Epiendo Pharmaceuticals ehf.

Obesity+1

Not recruiting

Phase 1 randomized, placebo-controlled study of ROSE-010 and paracetamol on appetite in overweight and obese adults

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Paracetamol
  • Sponsor:Rose Pharma Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.